Extracorporeal Shock Wave Lithotripsy Market Size

Extracorporeal Shock Wave Lithotripsy Market in 2025 is assessed at USD 468.08 million. The global market size was valued at over USD 447.32 million in 2024 and is expected to grow at a CAGR of more than 5.8%, surpassing USD 930.96 million by 2037. North America is projected to attain USD 297.91 million by 2037, driven by a large number of diabetic and obese patients prone to kidney stones and gallstones, supported by a strong healthcare network and regulatory backing.

The major factor attributed to the expansion of the market is the rising cases of kidney stones among the global population owing to the engagement in a sedentary lifestyle and consumption of a high amount of fatty and processed food items. Recent statistics stated that the prevalence of kidney stones varies from region to region. For instance, in 2022 it was calculated that the prevalence rate of kidney stones is almost 1-5% in Asia, 5-9% in Europe, and 7-15% in North America. At the same time, approximately 20% of the population in Saudi Arabia and only 4% population in China were diagnosed with kidney stones.

In addition to kidney stones, the global extracorporeal shock wave lithotripsy (ESWL) market is also estimated to increase owing to the rise in ureter stones and gallstones. Also, the rising preference for minimally invasive procedures is expected to increase the utilization rate of extracorporeal shock wave lithotripsy (ESWL) for destructing of hardened masses such as kidney stones, bezoars, and gallstones during the forecast period. Furthermore, the escalation in patient awareness of recent technological advancements in the healthcare industry along with the high investments made in the medical devices sector is expected to drive market growth in the upcoming years. Additionally, the increasing awareness level about the advantages of extracorporeal shock wave lithotripsy (ESWL) which includes minimal invasiveness, reduced pain, shorter hospital stay, quicker recovery time, and enhanced overall patients experience is projected to create a positive outlook for market expansion and impetus a significant revenue generation in the forecast period.